Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.
- Year invested 2019
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website bdtherapeutics.com
- Company Status Private